Results 171 to 180 of about 35,059 (247)

Ubiquitination and Deubiquitination: From Molecular Mechanisms to Therapeutic Strategies

open access: yesMedComm, Volume 7, Issue 11, November 2026.
Ubiquitination and deubiquitination form a reversible regulatory network that controls protein stability, localization, interactions, chromatin association, and signaling. E3 ligases generate distinct ubiquitin signals; DUBs remove or remodel them; and ubiquitin‐binding proteins decode chain topology and cellular context.
Wanqing Liu   +5 more
wiley   +1 more source

Proteomic analysis of oxidative modifications in human atherosclerotic plaques and control arteries. [PDF]

open access: yesRedox Biol
Yang-Jensen KC   +5 more
europepmc   +1 more source

Optimized Roflumilast Ethosomal Gel for Enhanced Transdermal Therapy in Atopic Dermatitis: An In Vitro Study

open access: yesChemistryOpen, Volume 15, Issue 11, November 2026.
Roflumilast‐loaded ethosomal gel was developed and optimized using a Design of Experiments approach for enhanced transdermal delivery. The optimized RT‐5 formulation exhibited suitable pH, viscosity, spreadability, stability, and microbiological quality, achieving 99.34% drug penetration after 12 h, demonstrating promising topical delivery potential ...
Yasir Mehmood   +11 more
wiley   +1 more source

Protosappanin A Alleviates Atherosclerosis by Regulating the MDM2/GPX4 Axis‐Mediated Endothelial Ferroptosis

open access: yesPhytotherapy Research, Volume 40, Issue 11, Page 6450-6467, November 2026.
PTA alleviates atherosclerosis by regulating the MDM2/GPX4 axis‐mediated endothelial ferroptosis. ABSTRACT Endothelial ferroptosis is a crucial pathogenic driver of atherosclerosis (AS) progression. Protosappanin A (PTA), a bioactive compound from Caesalpinia sappan L., protects cardiovascular vessels by regulating ferroptosis.
Jiamei Fu   +6 more
wiley   +1 more source

Superior Clinical and Economic Value of IL‐23 Inhibitors Versus Adalimumab Biosimilars in Plaque Psoriasis

open access: yesInternational Journal of Dermatology, Volume 65, Issue 11, Page 2362-2370, November 2026.
A bicentric retrospective real‐world study (N = 616) comparing IL‐23 inhibitors (guselkumab, risankizumab, tildrakizumab) with adalimumab biosimilars in moderate‐to‐severe plaque psoriasis. It presents PASI90 response at Weeks 16 and 52, NNT, and cost‐effectiveness (incremental cost per responder, CE plane, CEAC/CEAF).
Gennaro Marco Falco   +13 more
wiley   +1 more source

Interleukin‐12: Central Roles in Immune Regulation and Disease Therapy

open access: yesImmunology &Cell Biology, Volume 104, Issue 10, Page 996-1014, November‐December 2026.
IL‐12 levels are tightly regulated to balance effective protective immunity against infections and cancer with the risk of excessive inflammation and autoimmune disease. Both insufficient and excessive IL‐12 activity can therefore be detrimental, highlighting the importance of precisely controlling its production and signaling. ABSTRACT Interleukin‐12 (
Anthi Psoma, Geert van den Bogaart
wiley   +1 more source

Lipoprotein(a), Endothelial Dysfunction and Cardiovascular Disease

open access: yesJournal of Cellular and Molecular Medicine, Volume 30, Issue 21, November 2026.
ABSTRACT Lipoprotein(a) (Lp(a)) is a particle similar to low‐density lipoprotein cholesterol and is associated with apolipoprotein (A). High Lp(a) levels are a genetic, independent risk factor for atherosclerotic cardiovascular disease (ASCVD). Endothelial cells, which form the continuous lining of the cardiovascular system, are crucial for vascular ...
Xianghui Zhou   +5 more
wiley   +1 more source

Time-dependent prognostic value of coronary plaque burden and hyperemic myocardial blood flow. [PDF]

open access: yesEur J Nucl Med Mol Imaging
Dahdal J   +15 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy